UpdatesPress Release
Thyrocare reported strong Q1FY27 results: Revenue surged 24% YoY to ₹240.02 Cr, EBITDA 34% to ₹77.27 Cr, and PAT 34% to ₹51.33 Cr.
Thyrocare Technologies LimitedTHYROCARE · Filed with the exchange
It processed 55.2 million tests, up 28%. The company also expanded into Specialty Diagnostics.
No comments yet. Be the first.